Neurogene Inc. (NGNE) has reported a lower-than-expected loss for the first quarter, outperforming Wall Street predictions.
The company's net loss registered at approximately $16.921 million or -$1 per share. This is a slight improvement when compared to the loss of $12.263 million, or -$28.28 per share, reported in last year's first quarter.
Bearing in mind that Thomson Reuters had compiled the average analysts' expectations for the company to post a loss of $1.13 per share, Neurogene Inc. has indeed fared better than anticipated. It is worth noting that these estimates generally don't account for exceptional items.
Here's a brief review of Neurogene Inc.'s earnings according to GAAP:
Their earnings for Q1 show a loss of $16.921 million, in contrast to the loss of $12.263 million during the same period last year. Neurogene Inc.'s earnings per share (EPS) for Q1 are perched at -$1, markedly better than the -$28.28 recorded in Q1 of the previous year.
